For: | Perisetti A, Goyal H, Yendala R, Thandassery RB, Giorgakis E. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements. World J Gastroenterol 2021; 27(24): 3466-3482 [PMID: 34239263 DOI: 10.3748/wjg.v27.i24.3466] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v27/i24/3466.htm |
Number | Citing Articles |
1 |
Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Silvia Gaia, Emanuela Rolle, Alessandra Risso, Daniela Campion, Paola Rita Brunocilla, Giorgio Maria Saracco, Patrizia Carucci. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy. Current Oncology 2022; 29(3): 1422 doi: 10.3390/curroncol29030119
|
2 |
Heng-Tong Han, Wei-Lin Jin, Xun Li. Mesenchymal stem cells-based therapy in liver diseases. Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00088-x
|
3 |
Bahareh Farasati Far, Dorsa Rabie, Parisa Hemati, Parastoo Fooladpanjeh, Neda Faal Hamedanchi, Nima Broomand Lomer, Arian Karimi Rouzbahani, Mohammad Reza Naimi-Jamal. Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy. Livers 2023; 3(1): 121 doi: 10.3390/livers3010011
|
4 |
Chunyan Yuan, Jing Peng, Renxiang Xia, Jian He, Tianji Qiu, Yunqing Yao. Reactivation of Occult Hepatitis B Virus Infection During Long-Term Entecavir Antiviral Therapy. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.865124
|
5 |
Reshmi Mathew, Gregory Churchill, Bakht Cheema, Ketav Desai, Ahmad Alkhasawneh, Shiguang Liu, Anwer Siddiqi. Concomitant Gastric Malignancy and Hepatocellular Carcinoma. Cureus 2022; doi: 10.7759/cureus.25607
|
6 |
Luckshi Rajendran, Woo Jin Choi, Hala Muaddi, Tommy Ivanics, Jordan J. Feld, Marco P. A. W. Claasen, Matthew Castelo, Gonzalo Sapisochin. Association of Viral Hepatitis Status and Post-hepatectomy Outcomes in the Era of Direct-Acting Antivirals. Annals of Surgical Oncology 2023; 30(5): 2793 doi: 10.1245/s10434-022-12937-8
|
7 |
Saleh A. Alqahtani, Wah-Kheong Chan, Ming-Lung Yu. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma. Clinics in Liver Disease 2023; 27(2): 211 doi: 10.1016/j.cld.2023.01.019
|
8 |
Qinglin Zhang, Jiadong Pan, Fangmei An, He Nie, Qiang Zhan. Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma. Bioengineered 2021; 12(1): 8147 doi: 10.1080/21655979.2021.1987131
|
9 |
Yu Jiang, Shulin Chen, Yaxian Wu, Yuanye Qu, Lina Jia, Qingxia Xu, Shuqin Dai, Ning Xue. Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02725-5
|
10 |
Yan Zhu, Zhishuai Li, Jixiang Zhang, Mingqi Liu, Xiaoqing Jiang, Bin Li. Identification of crucial lncRNAs and mRNAs in liver regeneration after portal vein ligation through weighted gene correlation network analysis. BMC Genomics 2022; 23(1) doi: 10.1186/s12864-022-08891-0
|
11 |
Ellery Altshuler, Raymond Richhart, Mahmoud Aryan, William King, Kelsey Pan, Akash Mathavan, Akshay Mathavan, Diana Rodriguez, Bishal Paudel, Nathan Northern, Brian Ramnaraign, Ilyas Sahin, Jesus C Fabregas. Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review. Journal of Hepatocellular Carcinoma 2022; : 1299 doi: 10.2147/JHC.S384438
|